Inventor
DRUCKER DANIEL J
CA27 patents
⚠️ This page may combine multiple inventors who share the name “DRUCKER DANIEL J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ONTARIO INC 1149336
13 patentsUS5834428ANov 10, 1998
Glucagon-like peptide-2 and its therapeutic use
ONTARIO INC 1149336158 citations99
US6051557AApr 18, 2000
Methods of enhancing functioning of the upper gastrointestinal tract
ONTARIO INC 114933688 citations98
US5990077ANov 23, 1999
Glucagon-like peptide-2 and its therapeutic use
ONTARIO INC 1149336109 citations98
US5846937ADec 8, 1998
Method of using exendin and GLP-1 to affect the central nervous system
ONTARIO INC 1149336113 citations98
US7049284B2May 23, 2006
Glucagon-like peptide-2 and its therapeutic use
ONTARIO INC 114933662 citations96
US6586399B1Jul 1, 2003
Methods of enhancing functioning of the large intestine
ONTARIO INC 114933650 citations96
US6297214B1Oct 2, 2001
Methods of enhancing functioning of the large intestine
ONTARIO INC 114933637 citations96
US5952301ASep 14, 1999
Compositions and methods for enhancing intestinal function
ONTARIO INC 114933676 citations96
US5994500ANov 30, 1999
Antagonists of intestinotrophic GLP-2 peptides
ONTARIO INC 114933649 citations95
US7176182B2Feb 13, 2007
Methods of enhancing functioning of the large intestine
ONTARIO INC 114933623 citations92
US6489295B1Dec 3, 2002
Antagonists of intestinotrophic GLP-2 peptides
ONTARIO INC 114933628 citations92
US7960344B2Jun 14, 2011
Methods of enhancing functioning of the large intestine
ONTARIO INC 11493367 citations84
US7862824B2Jan 4, 2011
Enhancement of GLP-2 activity of suppressing appetite
ONTARIO INC 11493360 citations42
NPS PHARMA INC
4 patentsUS7642241B2Jan 5, 2010
Methods of enhancing functioning of the large intestine
NPS PHARMA INC8 citations84
US7888317B2Feb 15, 2011
Glucagon-like peptide-2 and its therapeutic use
NPS PHARMA INC3 citations63
US8846625B2Sep 30, 2014
Glucagon-like peptide-2 analogs
NPS PHARMA INC0 citations51
US7781401B2Aug 24, 2010
Glucagon-like peptide-2 analogs
NPS PHARMA INC0 citations51
DRUCKER DANIEL J
4 patentsUS8603976B2Dec 10, 2013
Methods of enhancing functioning of the large intestine
DRUCKER DANIEL J1 citations61
US8278273B2Oct 2, 2012
Methods of enhancing functioning of the large intestine
DRUCKER DANIEL J1 citations61
US8933039B2Jan 13, 2015
Glucagon-like peptide-2 analogs
DRUCKER DANIEL J0 citations50
US9168288B2Oct 27, 2015
Methods for treating disorders of the gastrointestinal tract using a GLP-1 agonist
DRUCKER DANIEL J0 citations41